Enabling Companies with Industry Leading Market Intelligence; Facilitating vital Pricing Data; and Advocating for Data Driven Solutions.
The company behind the superdosing concept, AB Vista, has been accumulating data and evidence to back up the benefits of phytase ever since the launch of its flagship E. coli phytase product Quantum Blue in the US in January 2012, and its subsequent European Union launch in 2014. Feedinfo spoke with Mike Bedford, Research Director at AB Vista, to assess the evolution of its phytase offering over the past decade and what opportunities still lie ahead. Take a listen! #enzyme #animalnutrition #Feedinfo #Mintec
Since the 90s, phytase has thrived in the feed enzyme market. 'Superdosing,' increasing phytase doses to counter phytate's negative effects on animals, has gained traction. AB Vista, the pioneer of superdosing, has collected data since 2012 to support the benefits of its Quantum Blue product. We interviewed AB Vista's Research Director, Mike Bedford, to discuss their phytase evolution and future prospects. Read the full article here: https://ow.ly/uFoP50Pf1fa
